You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 14, April 11, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Evidence-Based Medicine
 •Informatics/ Internet in Medicine
 •Informatics, Other
 •Diet
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Folic Acid Supplementation and Cardiovascular Diseases

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Several large prospective observational studies and a recent meta-analysis1 suggested an association between elevated levels of homocysteine and risk of cardiovascular diseases. A population-based cohort study found that folate supplementation is effective in decreasing total homocysteine concentration.2 However, the meta-analysis of randomized controlled trials by Dr Bazzano and colleagues3 did not find any effect of folic acid supplementation on the risk of cardiovascular diseases or all-cause mortality among patients with a prior history of vascular disease.

The authors suggested possible factors that may have contributed to the discrepancy between the results of their meta-analysis and those of observational studies, including the presence of confounding factors in observational studies, the lack of efficacy of folic acid supplementation in secondary prevention, and the beneficial effect of folic acid supplementation only in populations with specific genetic backgrounds or with folate deficiency. However, the inefficacy of folate supplementation in reducing the . . . [Full Text of this Article]

Francesco Dentali, MD
fdentali@libero.it

Monica Gianni, MD; Walter Ageno, MD
Department of Clinical Medicine
Insubria University
Varese, Italy


RELATED LETTERS

Folic Acid Supplementation and Cardiovascular Diseases
Suhal S. Mahid, Kyle S. Minor, and Susan Galandiuk
JAMA. 2007;297(14):1549.
EXTRACT | FULL TEXT  

Folic Acid Supplementation and Cardiovascular Diseases—Reply
Lydia A. Bazzano, Kristi Reynolds, Kevin N. Holder, and Jiang He
JAMA. 2007;297(14):1550.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials
Lydia A. Bazzano, Kristi Reynolds, Kevin N. Holder, and Jiang He
JAMA. 2006;296(22):2720-2726.
ABSTRACT | FULL TEXT  

Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration
JAMA. 2002;288(16):2015-2022.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.